Table 2. Hazard Ratios for Cardiovascular End Points in Relation to Clinic and Home Blood Pressure at Entry for the Whole Cohort and by Treatment Status.
| Fatal and Nonfatal Cardiovascular End Points Combined |
||||
|---|---|---|---|---|
| Blood pressure index | Cardiovascular Death | All | Stroke | Cardiac |
| All subjects (n=6470) | ||||
| End points, n | 294 | 716 | 393 | 336 |
| Systolic blood pressure | ||||
| Clinic | 1.11 (1.04–1.17)‡ | 1.09 (1.05–1.13)§ | 1.12 (1.06–1.17)§ | 1.05 (1.00–1.11) |
| Home | 1.13 (1.05–1.21)† | 1.19 (1.14–1.25)§ | 1.28 (1.20–1.37)§ | 1.10 (1.03–1.18)† |
| Diastolic blood pressure | ||||
| Clinic | 1.05 (1.00–1.11) | 1.07 (1.04–1.11)§ | 1.09 (1.04–1.14)‡ | 1.04 (0.99–1.10) |
| Home | 1.04 (0.97–1.11) | 1.13 (1.08–1.17)§ | 1.19 (1.13–1.25)§ | 1.05 (0.99–1.12) |
| Treated (n=1452) | ||||
| End points, n | 136 | 302 | 168 | 142 |
| Systolic blood pressure | ||||
| Clinic | 1.02 (0.93–1.11) | 1.01 (0.96–1.07) | 1.07 (0.99–1.16) | 0.94 (0.86–1.02) |
| Home | 1.16 (1.04–1.29)‡ | 1.15 (1.08–1.24)§ | 1.31 (1.18–1.45)§ | 1.03 (0.93–1.14) |
| Diastolic blood pressure | ||||
| Clinic | 1.00 (0.93–1.08) | 1.03 (0.98–1.08) | 1.04 (0.97–1.11) | 1.00 (0.92–1.08) |
| Home | 1.07 (0.97–1.19) | 1.11 (1.04–1.17)† | 1.19 (1.10–1.29)§ | 1.00 (0.91–1.11) |
| Untreated (n=5018) | ||||
| End points, n | 158 | 414 | 225 | 194 |
| Systolic blood pressure | ||||
| Clinic | 1.19 (1.10–1.28)§ | 1.15 (1.09–1.20)§ | 1.15 (1.08–1.23)§ | 1.15 (1.07–1.23)‡ |
| Home | 1.10 (1.00–1.21) | 1.21 (1.14–1.28)§ | 1.26 (1.16–1.37)§ | 1.16 (1.06–1.26)‡ |
| Diastolic blood pressure | ||||
| Clinic | 1.10 (1.02–1.18)* | 1.11 (1.06–1.16)§ | 1.13 (1.07–1.20)§ | 1.08 (1.00–1.15)* |
| Home | 1.00 (0.91–1.09) | 1.14 (1.08–1.20)§ | 1.18 (1.09–1.27)§ | 1.08 (1.00–1.18) |
Hazard ratios (95% CIs) reflect the risk associated with 10- and 5-mm Hg increases in systolic and diastolic blood pressure, respectively. Hazard ratios were adjusted for cohort, sex, age, body mass index, smoking, history of cardiovascular disease, diabetes mellitus, treatment with antihypertensive drugs, and serum total cholesterol. The associations between clinic systolic blood pressure and cardiovascular end points were markedly steeper in the untreated as compared with the treated population (P<0.05 for all comparisons).
Significance of the hazard ratios:
P≤0.05;
P≤0.01;
P≤0.001;
P≤0.0001.